Submission Details
| 510(k) Number | K881816 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 28, 1988 |
| Decision Date | July 28, 1988 |
| Days to Decision | 91 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
K881816 is an FDA 510(k) clearance for the ABUSCREEN(R) ONTRAK(TM) FOR BARBITURATES, a Radioimmunoassay, Barbiturate (Class II — Special Controls, product code DKN), submitted by Roche Diagnostic Systems, Inc. (Montclair, US). The FDA issued a Cleared decision on July 28, 1988, 91 days after receiving the submission on April 28, 1988. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3150.
| 510(k) Number | K881816 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 28, 1988 |
| Decision Date | July 28, 1988 |
| Days to Decision | 91 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | — |
| Product Code | DKN — Radioimmunoassay, Barbiturate |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3150 |